Latest stories on ENTA
Enanta Pharma GAAP EPS of -$0.67 misses by $0.16, revenue of $14.35M misses by $2.47M
Seeking Alpha34 · bearishearnings
Enanta Reports Q3 Eps 67c Consensus 51c
The Fly72 · bullishearnings
ENANTA PHARMACEUTICALS INC (ENTA) files 8-K
SEC 8-K50 · neutralgeneral
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
StockTitan56 · neutralearnings
ENANTA PHARMACEUTICALS INC (ENTA) files 8-K
SEC 8-K50 · neutralgeneral
Enanta Faces Patent Setback in Paxlovid Litigation
TipRanks34 · bearishgeneral
ENANTA PHARMACEUTICALS INC (ENTA) files 8-K
SEC 8-K50 · neutralgeneral
Pfizer patent win against Enanta over COVID pill upheld by appeals court
Seeking Alpha67 · bullishgeneral
AbbVie, Enanta announce EU label expansion for hepatitis C therapy, Maviret
Seeking Alpha67 · bullishproduct/pr
Enanta Advances RSV Antiviral Zelicapavir to Registrational Trial
TipRanks67 · bullishproduct/pr
ENANTA PHARMACEUTICALS INC (ENTA) files 8-K
SEC 8-K50 · neutralgeneral
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | ENTA Stock News
StockTitan56 · neutralgeneral